Siemens Healthineers (ETR:SHL) Stock Price Up 0.1% - Still a Buy?

Key Points

• Siemens Healthineers AG saw a slight increase in stock price, rising by 0.1% to €47.32 ($55.67) with a market capitalization of $53.39 billion.
• The company reported a P/E ratio of 27.51 and a beta of 0.70, indicating a relatively stable stock compared to the market.
• Siemens Healthineers operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies, providing a variety of diagnostic and therapeutic healthcare solutions.

Siemens Healthineers AG (ETR:SHL - Get Free Report)'s share price was up 0.1% during mid-day trading on Friday . The stock traded as high as €47.91 ($56.36) and last traded at €47.32 ($55.67). Approximately 336,263 shares changed hands during mid-day trading, The stock had previously closed at €47.26 ($55.60).

Siemens Healthineers Price Performance

The stock's 50 day simple moving average is €47.05 and its 200-day simple moving average is €47.38. The firm has a market cap of $53.20 billion, a price-to-earnings ratio of 27.41, a price-to-earnings-growth ratio of 1.16 and a beta of 0.70. The company has a debt-to-equity ratio of 89.20, a quick ratio of 0.71 and a current ratio of 1.25.

Siemens Healthineers Company Profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.